SANOFI-AVENTIS (EPA:SAN)

PRESS RELEASE

published on 02/17/2026 at 12:00, 6 months 21 days ago

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD

Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF

published on 02/16/2026 at 07:05, 6 months 23 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
BRIEF

published on 02/16/2026 at 07:05, 6 months 23 days ago

Beyfortus proves its effectiveness beyond the first season of VRS

Sanofi VRS Beyfortus Infants Immunization
PRESS RELEASE

published on 02/16/2026 at 07:00, 6 months 23 days ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings

RSV Beyfortus Infants Immunization Hospitalizations
BRIEF

published on 02/10/2026 at 15:05, 7 months ago

Sanofi Finalizes Acquisition of Dynavax

Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE

published on 02/10/2026 at 15:00, 7 months ago

Press Release: Sanofi completes the acquisition of Dynavax
Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities

Acquisition Sanofi Vaccine Immunization Dynavax
BRIEF

published on 02/03/2026 at 07:05, 7 months 8 days ago

Sanofi Signs €1 Billion Share Buyback Mandate

Share Buyback Investment Financial Strategy Biopharma Sanofi
PRESS RELEASE

published on 02/03/2026 at 07:00, 7 months 8 days ago

Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026

Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF

published on 01/30/2026 at 13:05, 7 months 11 days ago

Sanofi's Rezurock Recommended for EU Approval by CHMP

Sanofi EU Market CHMP Approval Rezurock Chronic GVHD
BRIEF

published on 01/30/2026 at 13:05, 7 months 11 days ago

The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD

Treatment Sanofi Rezurock CHAMP GVHD

Published on 09/11/2026 at 04:00, 6 hours 38 minutes ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 13 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 16 hours 52 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 19 hours 18 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 19 hours 38 minutes ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

Published on 09/11/2026 at 10:15, 23 minutes ago

TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 18 minutes ago

Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 1 hour 33 minutes ago

ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 1 hour 38 minutes ago

Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 09:00, 1 hour 38 minutes ago

Picton Property Income Limited - Removal

View all EQS

Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 3 hours 38 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 15 hours 8 minutes ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 07:00, 1 day 3 hours ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 1 day 15 hours ago

Successful launch of a €500 million bond issue

View all LES ECHOS COMFI WIRE

News